Within 24 h of culture in vitro, the supernatant from five of six conceptuses showed detectable antiviral activity. Interferon \g=a\(IFN-\g=a\)receptors were identified by immunohistochemistry on the luminal surface of the endometrium, in the neurohypophysis and paraventricular hypothalamus, but not in the ovaries of the hinds from which the conceptuses were collected. Another 16 intact hinds were synchronized as above. Injection of 4 mg IFN i.m. twice a day on days 13\p=n-\15had no effect on cloprostenol-induced oxytocin secretion on day 15 and did not prevent cloprostenol\x=req-\ induced luteal regression. Sixteen ovariectomized hinds received a protocol of steroid treatment to mimic ovarian hormone secretion during the normal oestrous cycle. On day 16, hinds showed undulant oxytocin secretion that showed a degree of temporal association with uterine PGF2\g=a\ release. Treatment with 4 mg IFN-\g=a\11twice a day on days 13\p=n-\16had no effect on this spontaneous oxytocin secretion, but reduced the magnitude of cloprostenol-induced oxytocin secretion on day 17 (P < 0.05). These results indicate that red deer conceptuses secrete an anti-luteolytic IFN to which the endometrium expresses a receptor during early pregnancy. The presence of IFN receptors in the hypothalamus and posterior pituitary and the IFN-induced suppression of extra-ovarian oxytocin secretion provides tentative evidence of an involvement of the central nervous system in maternal recognition of pregnancy in deer.
Introduction
Successful establishment of pregnancy in eutherian mammals is dependent on maintenance of the progesteronesecreting corpus luteum (Flint et ah, 1990) . In polyoestrous mammals, the embyro or embryos must prevent the destruction of the corpus luteum at luteolysis, a process known as the maternal recognition of pregnancy (Short, 1969) . In cattle and sheep, this is achieved by conceptus secretion of IFN-, which reduces endometrial oxytocin sensitivity, suppresses pulsatile uterine PGF2a secretion and thus prevents luteolysis (Bazer, 1992; Bazer et ah, 1997) . IFNshows a high degree of homology with bovid IFNs (Stewart et ah, 1987) and both and IFNs are thought to bind to the same receptor on the endometrium, the type 1 IFN receptor (Lim and Langer, 1993; Li and Roberts, 1994) .
Recently, more information has been gained on the mechanisms underlying maternal recognition of pregnancy in another group of ruminants, the Cervidae. In red deer, natural luteolysis is associated with synchronous pulsatile release of ovarian oxytocin and luteolytic PGF2ct (Bainbridge and Jabbour, 1997). Secretion of these hormones is thought to be mediated by a positive feedback loop between the uterus and the ovary (Flint et ah, 1991 (Flint et ah, , 1994 , and this loop is activated at the end of the luteal phase by increasing endometrial oxytocin sensitivity that occurs under the control of ovarian steroids (Bainbridge et ah, 1996a,b) . However, the initiating factor of each individual pulse of luteolytic hormone release is unknown (Bainbridge and Jabbour, 1997).
There is considerable evidence that the conceptus antiluteolytic factor in red deer is also an IFN. Uterine flushings from pregnant red deer hinds show antiviral activity (Flint, 1995) and administration of exogenous IFN-a suppresses uterine oxytocin sensitivity, pulsatile secretion of oxytocin and PGF2a, and luteolysis itself (Bainbridge et ah, 1996b;  Bainbridge and Jabbour, 1997). However, certain aspects of the pregnancy recognition system in red deer remain to be elucidated. Firstly, IFN secretion by isolated red deer conceptuses has not been reported. Secondly, no receptors for IFN have been demonstrated in any reproductive tissue in red deer. Thirdly, the relative importance of local and systemic actions of conceptus IFN are unknown: although IFNis thought to act locally within the uterus in bovids (Lamming et ah, 1995) , antiviral activity is also detectable in the uterine venous effluent of pregnant sheep (Schalue-Francis et ah, 1991) . No data have been published regarding the site of action of putative conceptus IFNs in deer.
The aim of this study was to elucidate the mechanisms underlying maternal recognition of pregnancy in red deer by investigating the source and site of action of the putative anti-luteolytic IFN. Red deer conceptuses were cultured in vitro and their IFN secretion was assessed. The distribution of IFN-rx and IFNreceptors in female reproductive tissues was determined by immunohistochemistry and the effects of exogenous IFN on ovarian and non-ovarian oxytocin secretion were studied using intact and steroid-treated ovari¬ ectomized hinds.
Materials and Methods

Animals
Experiments 1 and 2 were conducted at ADAS Rosemaund Research Centre, Herefordshire, UK (52°10"N) during the breeding season. Ten mature red deer hinds with a mean (± sd) live weight of 93.2 ± 8.2 kg were used. Experiments 3, 4 and 5 were conducted at the Institute of Zoology Laboratory at Whipsnade Wild Animal Park, Bedfordshire, UK (51°50'N) in autumn 1995. In these experiments, 16 mature intact red deer hinds with a mean (± SD) live weight of 99.5 ± 5.2 kg and 16 mature ovari¬ ectomized red deer hinds with a mean (± sd) live weight of 103.3 ± 10.4 kg were used. Experiment 1: quantification of IFN secretion by red deer conceptuses Ten hinds were treated with two progesterone releasing intravaginal controlled internal drug releasing devices (CIDR type G, 0.3 g progesterone per device; Carter Holt Harvey Plastic Products, Hamilton). The first CIDR device was inserted for 8 days and was replaced with a second device for 5 days. All hinds were run with a fertile stag after removal of CIDR devices. Twenty-two days after removal of CIDR devices, all hinds were killed and the uterus removed within 5 min. The uterus was separated from the vagina, oviducts and ovaries; the mesometrium was trimmed and the uterine body was bisected sagittally. A blunt needle was introduced into the proximal end of each uterine horn and the conceptus was flushed from the pregnant horn with 25 ml Hepes-buffered medium 199 (Gibco BRL Life Technologies, Paisley).
The six conceptuses obtained (one conceptus from each of six hinds) were cultured for 24 h using a modified version of the technique described by Godkin et ah (1992) . After three rinses in Hepes-buffered medium 199, each conceptus was placed in 30 ml minimum essential medium with Earl's salts and glutamine (Gibco) with the addition of 0.2 iu bovine insulin ml-1, 200 iu penicillin ml·1, 200 pg streptomycin sulphate mL1 (Sigma, Poole), 500 ng amphotericin ml·1 (fungizone; Gibco) and 1% (v/v) non-essential amino acid preparation (Gibco) . The culture was maintained in an atmosphere of 50% nitrogen, 45% oxygen and 5% carbon dioxide at 38°C. The cultures were then chilled on ice and centrifuged at 2000 g for 1 h at 4°C. The supernatant was decanted and stored at -20°C before the IFN assay. The pellet was stored at -20°C before determination of nucleic acid content.
The IFN activity of the supernatant and an aliquot of medium aspirated after 5 h of culture was measured by the Madin-Darby bovine kidney cell-Semliki Forest virus cytopathic effect inhibition assay described by Abayasekara et ah (1995) and the sensitivity of this assay was 100 iu ml"1. All samples were included in a single assay. A laboratory standard preparation of recombinant bovine IFN-, (rBoIFN-, ; Ciba-Geigy, Basle) was calibrated against a sample of the 1st international standard preparation of human EFN-OL (1987) and used for generating the standard curve in the assay.
Each conceptus pellet was lysed by agitation at 37°C for 24 h in a Tris-HCl buffered solution of sodium dodecyl sulphate (33 g l"1; BDH Laboratory Supplies, Poole) and proteinase (330 pg l"1; Sigma). Nucleic acid was extracted by serial equilibration over (i) phenol (BDH), (b) a 1:1 mixture of phenol and chloroform (BDH) and (c) chloroform. The spectrophotometric absorbance of the resulting aqueous phase at 260 nm was measured and used to calculate the concentration of nucleic acids in the solution.
Experiment 2: histological localization of IFN receptors
Localization of IFN receptors in red deer tissues was acheived by double-antibody fluorescence immunohisto¬ chemistry. The primary antibody (IFNRAC-abr; Research Diagnostics Inc., Flanders, NJ) was raised in rabbits against a recombinant fusion protein containing the cytoplasmic portion of subunit 1 of the human IFN-ot receptor (IFNaRl).
Uterus, ovary, pituitary and hypothalamus tissue was collected from the pregnant hinds killed in Expt 1, frozen in polyethylene bags on dry ice and stored at -70°C. Tissues were cut into 7 pm sections and transferred to glass slides coated with 3-aminopropyltriethoxy-silane (Sigma). After dehydration at 4°C for at least 2 h, sections were fixed for 2 min in acetone.
Dilution buffer was made up as follows: 10 mmol PBS l·1 (pH 7.4) with 10 g BSA H, 10 g fish gelatin l"1 and 0.05% (v/v) Tween-20 detergent (Sigma). A section from each tissue was incubated (i) for 30 min with normal goat serum (Dako A/S, Glostrup) diluted 1:30 in dilution buffer, (ii) for 1 h with lOpgml"1 primary antibody to IFNaRl in dilution buffer and (iii) for 1 h in the dark with 6.9 pg mL1 affinity isolated fluorescein isothiocyanate (FITC)-conjugated goat antirabbit IgG (Sigma). Between each incubation the sections were washed in 10 mmol PBS l·1 (pH 7.4) with 1 g BSA l"1, and after the last incubation the sections were mounted in Citifluor (UKC, Canterbury) and viewed under ultraviolet light. Sections were then re-stained using a conventional haematoxylin technique. In each tissue, an adjacent section was treated in the same way except the anti-IFNccRl antibody was replaced by normal rabbit serum (Gibco) diluted 1:1000 in dilution buffer.
Experiment 3: effect ofexogenous IFN on luteal function
The antiviral activity of the rBoIFN-, preparation was measured by the Madin-Darby bovine kidney cell-Semliki Forest virus cytopathic effect inhibition assay described by Abayasekara et ah (1995) and was found to be 1.32 IO8 iu mg"1 protein.
A total of 16 hinds were allocated to one of two treatment groups (n = 8 per group) adjusted for live weight. Each hind was treated with two CIDR devices as described in Expt 1 (removal of device = day 0). Group 1 received no further treatment and served as controls. Group 2 received i.m. injections of 4 mg rBoIFN-, in 1.6 ml sterile water twice a day from day 13 to day 15.
Hinds received a single cloprostenol challenge on day 15. A dose of 500 pg of the PGF2ct analogue cloprostenol (2 ml Estrumate; Pitman-Moore Ltd, Crewe) was injected into the middle gluteal muscle. Jugular blood samples (5 ml) were collected 48 and 24 h before and 0, 6,12,18,24,36,48,60 and 72 h after the cloprostenol injection, and plasma progesterone concentrations were analysed. In addition, blood samples (10 ml) were collected 30, 20 and 10 min before and 5,10, 20, 30 and 40 min after the cloprostenol injection and plasma oxytocin concentrations were analysed. Experiment 4: endogenous oxytocin and PGF,"secretion in ovariectomized hinds Six ovariectomized hinds received a treatment regimen known to induce plasma progesterone profiles and temporal changes in uterine oxytocin sensitivity similar to those of intact cyclic hinds (Bainbridge et ah, 1996b). Each hind was treated with two CIDR devices as described in Expt 1 (removal of device = day 0). After removal of the first CIDR device, all hinds underwent a programme of steroid treatment as follows: i.m. injection of 50 pg oestradiol benzoate (Sigma Chemical Company, St Louis, MO) in peanut oil at -24 and -12 h; 100 pg oestradiol benzoate at 0, 12,24,36 h; insertion of two successive CIDR devices from day 3 to day 18; 50 pg oestradiol benzoate twice a day on day 18. Blood samples (10 ml) were collected at intervals of 1 h for 16 h on days 4, 10, 16 and 18, and the samples were divided into two aliquots before storage at -20°C. One aliquot was used for determination of concentrations of oxytocin and the other aliquot for determination of 13,14-dihydro-15-keto prostaglandin F2a (PGFM), the pulmonary metabolite of prostaglandin F2a.
Experiment 5: effect ofexogenous IFN on extra-ovarian oxytocin secretion Ten ovariectomized hinds were allocated to one of two treatment groups (n = 5 per group) adjusted for live weight and all hinds received the steroid treatment described in Expt 4. Group 1 received no further treatment and served as controls. Group 2 received i.m. injections of 4 mg rBoIFN-, in 1.6 ml sterile water twice a day from day 13 to day 16.
On day 16, jugular blood samples (10 ml) were collected from all hinds at 1 h intervals for 16 h. On day 17, all hinds received a single 500 pg cloprostenol challenge as described in Expt 3. Blood samples (10 ml) were collected 30, 20 and 10 min before and 5, 10, 20, 30 and 40 min after the cloprostenol injection. All plasma samples harvested were analysed for oxytocin concentration.
Radioimmunoassays
Plasma progesterone concentrations were measured in duplicate using a radioimmunoassay validated for red deer (Argo and Loudon, 1992). The interassay coefficients of variation (CV) for red deer control samples with mean concentrations of 1.20, 0.43 and 0.095 ng ml"1 were 9.2, 9.0 and 20.1%, respectively, and the intra-assay CV were 4.2, 5.8 and 10.1%, respectively. The sensitivity of the assay was 0.033 ng ml"1 (defined as sample concentration corresponding to the mean minus twice the standard deviation of the total binding).
Plasma oxytocin concentrations were measured in duplicate using a radioimmunoassay method validated for red deer (Bainbridge and Jabbour, 1997). The interassay CV for red deer control samples with mean concentrations of 33.0, 6.84 and 2.33 ng ml"1 were 8.8, 11.0 and 16.2%, respectively, and the intra-assay CV were 4.1, 7.2 and 9.2%, respectively. Assay sensitivity (as defined above) was 0.4 ng ml"1.
Plasma concentrations of PGFM were measured in duplicate using a radioimmunoassay method validated for red deer (Bainbridge et ah, 1996a). The interassay CV for controls with mean concentrations of 340.0 and 60.2 pg ml-1 were 12.8 and 12.3%, respectively, and the intra-assay CV were 10.3 and 8.1%, respectively. The sensitivity of the assay (defined earlier) was 30 pg ml"1.
Statistical analyses
In Expt 1, the relationship between IFN production and nucleic acid content was investigated by linear regression. In Expts 3 and 5, the effects of IFN treatment on endocrine parameters were analysed by least squares regression analysis. In Expt 4, endogenous hormone secretion was analysed as described by Bainbridge and Jabbour (1997). A pulse of hormone secretion was defined as a time point when the plasma hormone concentration exceeded the mean + 2 sd for that hind. Data were analysed by the chi-squared test (number of hinds showing synchronous episodes of hormone secretion).
Results
Experiment 1: quantification of IFN secretion by red deer conceptuses
Conceptuses collected on day 22 after removal of CIDR devices (approximately 20 days after oestrus) showed the (Table 1) . There was a positive association between IFN production within 5 h and the nucleic acid content of the conceptus (n = 6, r2 = 0.844, < 0.01), although this was not true of IFN production after 24 h in culture (n = 6, r2 = 0.427, > 0.05).
Experiment 2: histological localization of IFN receptors
The intercaruncular endometrium was formed into multiple fronds of epithelial cells constituting a complex luminal surface. FITC fluorescence was apparent at the luminal surface of these fronds throughout the inter¬ caruncular areas (Fig. la-c) . The uterine caruncles consisted largely of connective tissue and blood vessels and contained less epithelial tissue, although this showed FITC fluores¬ cence (Fig. ld-f ). The caruncles also contained strongly autofluorescent granules, possibly fibrous or elastic material. The ovary showed little specific FITC binding in either luteal or follicular tissue ( Fig. lg-i) . The posterior pituitary showed scattered focal areas of FITC fluorescence ( Fig. lj-1) , as did the paraventricular region of the hypothalamus (Fig. lm-o ).
Experiment 3: effect ofexogenous IFN on luteal function
There was no significant effect of IFN treatment on plasma oxytocin secretion either before or after cloprostenol challenge (P > 0.1, Fig. 2a ). There was no effect of IFN treatment on plasma concentrations of progesterone before cloprostenol challenge (P > 0.1, Fig. 2b ). Plasma progesterone concentrations were lower in IFN-treated hinds than in control hinds 6 h after cloprostenol administration (P < 0.05) and were higher in IFN-treated hinds than in control hinds 24,32 and 72 h after cloprostenol treatment (all < 0.05).
Experiment 4: endogenous oxytocin and PGFM secretion in ovariectomized hinds
Individual oxytocin and PGFM profiles of the six hinds on day 16 are shown (Fig. 3 ). On day 16, hinds showed low amplitude undulant secretion of oxytocin. A greater proportion of hinds showed synchronous pulses of oxytocin and PGFM on day 16 than on days 4, 10 and 18 (3/6 versus 0/6, 0/6, 0/6; < 0.05). Two hinds also showed apparently asynchronous pulses of PGFM secretion.
Experiment 5: effect ofexogenous IFN on extra-ovarian oxytocin secretion
There was no significant effect of IFN treatment on the mean or variance of plasma oxytocin concentrations in ovariectomized hinds on day 16 (P > 0.1, > 0.1, Fig. 4a ) or on the mean oxytocin concentrations on day 17 before cloprostenol challenge (P > 0.1, Fig. 4b ). Plasma oxytocin concentrations increased after administration of cloprostenol (P < 0.00001) on day 17. Oxytocin concentrations were lower in the IFN-treated group than in the control group at 20, 30 and 40 min after cloprostenol treatment (all < 0.002).
Discussion
The results from Expt 1 of the present study are the first to demonstrate that the IFN activity present in the uterus of pregnant red deer (Flint, 1995) is secreted by the conceptus. Indeed, Bird et ah (1997) reported that the red deer conceptus contained IFN transcripts. It is proposed that the function of the conceptus IFN is to prevent luteolysis, since adminis¬ tration of exogenous IFN-a to red deer is known to suppress uterine oxytocin sensitivity, inhibit pulsatile secretion of oxytocin and PGF2o, and delay luteolysis (Bainbridge et ah, 1996b; Bainbridge and Jabbour, 1997). The class of the cervid IFN is not distinguished by antiviral assay, although cloning and sequencing of the genes encoding the peptide will elucidate any similarities to bovid , ß and IFNs. There is little information on cervid IFNs, although a gene similar to ovine IFN-has been detected in the white-tailed deer by hybridization of genomic DNA with a probe generated to ovine IFN-(Leaman and Roberts, 1992).
Although previous studies have investigated ruminant endometrial IFN receptors (Godkin et ah, 1984; Li and Roberts, 1994) , Expt 2 represents the first histological Fig. 1 . Sections of red deer tissues stained to detect the presence of IFN receptors. Three plates are presented for each tissue: (i) a section incubated with anti-IFN receptor rabbit IgG followed by fluorescein isothiocyanate (FITC)-conjugated anti-rabbit antibody; (ii) a negative control slide incubated with normal rabbit serum and FITC-conjugated anti-rabbit antibody; and (iii) the first section (i) stained with haematoxylin and photographed under bright-field microscopy. The tissues presented are (a-c) intercaruncular endometrium, (d-f) uterine caruncle, (g-i) ovary, with follicular antrum on the left and luteal tissue on the right, (j-1) neurohypophysis, and (m-o) hypothalamus in the region of the left paraventricular nucleus, with the third cerebral ventricle on the right. Scale bar represents 50 µ . homology, and the cytoplasmic domains are particularly homologous (Lim and Langer, 1993 ).
In the present study, the IFNaRl staining identified on the convoluted luminal surface of the intercaruncular endometrium presumably represents the primary binding site of the conceptus IFN, presenting a large area for IFN binding in direct apposition to the conceptus. The presence of IFN receptors on the endometrium may explain the marked suppressive effect of exogenous IFNs on uterine oxytocin sensitivity (Bainbridge et ah, 1996b) and pulsatile PGF2a secretion in red deer (Bainbridge and Jabbour, 1997). It is likely that the smaller amount of staining in the caruncular tissue reflects the specialized fibro-vascular nature of these fetal adhesion zones, which do not undergo the same degree of epithelial proliferation as the intercaruncular areas during early pregnancy. The low IFN receptor expression in the corpus luteum may explain why exogenous IFN did not exert a direct luteoprotective effect by suppressing the luteolytic effects of prostaglandin or prostaglandin-induced secretion of oxytocin in Expt 3. Similarly, the lack of IFN receptors on follicular cells in red deer hinds probably precludes the follicle as a site of action of anti-luteolytic IFNs. The physiological relevance of the IFN receptors detected in the central nervous system is uncertain. Both the paraventricular region and the posterior pituitary of red deer were notable for expression of IFN-aRl and this raises the possibility that conceptus IFNs may act at a site other than the endometrium. This proposal remains speculative, since the physiological reason for such a dual-site suppression of luteolysis by inhibition of both uterine PGF2a release and pituitary oxytocin secretion is unknown, and such a system has not been identified in any other species. In addition, IFN receptors may have a non-reproductive function in the central nervous system. However, pituitary oxytocin secretion has been postulated as the initiating factor in the synchronous episodes of oxytocin and PGF2a occurring at luteolysis in both sheep (McCracken et ah, 1996) and red deer (Bainbridge and Jabbour, 1996b). Thus, modulation of such secretion by conceptus IFNs may reflect a secondary mechanism of maternal recognition of pregnancy in some species. The results from Expt 3 indicate that IFN has no physiologically significant direct anti-luteolytic effect on the corpus luteum. Prostaglandin-induced oxytocin secretion in intact hinds during the late luteal phase was unaffected by IFN treatment. Treatment with IFN had a biphasic effect on progesterone secretion after injection of cloprostenol, but did not avert luteolysis. At 6 h after injection of cloprostenol, progesterone secretion in IFN-treated hinds was lower than that in control hinds, and this effect may be similar to the IFN-induced transient decrease reported in cattle (Plante et ah, 1991). After 24-72 h, progesterone concentrations were higher in IFN-treated hinds than in control hinds. Cloprostenol is thought to exert its primary luteolytic effect by acting directly on the corpus luteum (Sheldrick and Flint, 1985) , but may exert a minor indirect luteolytic effect by inducing luteal secretion of oxytocin, which, in turn, stimulates release of uterine PGF2a. Although cloprostenol induced luteal oxytocin release in IFN-treated hinds, such oxytocin would have a markedly suppressed PGF2areleasing effect on the desensitized endometrium. Thus, the smaller decrease in luteal progesterone secretion observed after IFN administration may be explained by an abrogation of a minor indirect luteolytic effect of cloprostenol.
Oxytocin secretion in ovariectomized hinds in Expt 4 was undulant and did not show the high amplitude peaks detected in intact hinds at luteolysis (Bainbridge and Jabbour, 1997 Although ovariectomized hinds lack luteal tissue, the magnitude of cloprostenol-induced oxytocin secretion was similar in intact hinds in Expt 3 and ovariectomized hinds in Expt 5. It is possible that this similarity reflects the nonphysiological nature of cloprostenol administration, which may stimulate oxytocin release over a different time course from that of an endogenous pulse of PGF2ct, and which is known to exhaust luteal stores of oxytocin in red deer (Flint et ah, 1991) . If extra-ovarian secretion is not exhausted in this way, this may explain why cloprostenol induces similar oxytocin secretion in intact and ovariectomized hinds, even though luteal secretion may exceed non-ovarian secretion at normal luteolysis. A second explanation for the similarity is that pituitary oxytocin secretion may be abnormally increased in ovariectomized hinds: ablation of luteal oxy¬ tocin secretion may reduce an inhibitory feedback effect of circulating oxytocin on the pituitary. Cloprostenol-induced extra-ovarian oxytocin secretion was reduced by administration of exogenous IFN-a. In addition to the immunohistochemical detection of IFN receptors in the posterior pituitary and paraventricular hypothalamus, this finding also indicates that central oxytocin-secreting neurones may be a secondary site of action of conceptus anti-luteolysins. Such an effect of IFNs would require transport of IFN from the uterine lumen to the brain, and it is not known whether this occurs in red deer.
Schalue-Francis et ah (1991) detected IFN in the venous effluent of pregnant ewes, although whether IFNcan subsequently cross the blood-brain barrier remains to be determined.
The present study extends current understanding of maternal recognition of pregnancy in red deer. The red deer conceptus secretes an IFN, and the endometrium and the paraventricular nucleus and neurohypophyseal unit express the type I IFN receptor. These results may explain why exogenous IFN suppresses uterine oxytocin sensitivity, delays luteal regression (Bainbridge et ah, 1996b) and inhibits cloprostenol-induced extra-ovarian oxytocin secretion, but has little direct effect on luteal secretion of oxytocin. The results also raise the possibility that red deer conceptus IFNs suppress luteolysis by acting at two sites to reduce pituitary oxytocin secretion as well as suppress uterine oxytocin sensitivity.
